AGX
Agenix
- Short interest
- 0.00%
- as of 14 July 2016
- Reported shorts
- 90
- Shares on issue
- 157.276M
Agenix (AGX) company profile
Profile, insiders and operations
Company
AI-generated research profile of Agenix
biotechnology
pharmaceuticals
ASX
innovation
healthcare
Agenix is a biotechnology company focused on developing innovative pharmaceuticals for unmet medical needs. The company leverages cutting-edge technology to create unique therapeutic solutions, aiming to improve patient outcomes and establish a strong presence in the healthcare market.
Director trades
No director trades found
AGX intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required